iHuman Inc. Files June 2024 Report (6-K)
Ticker: IH · Form: 6-K · Filed: Jun 28, 2024 · CIK: 1814423
Sentiment: neutral
Topics: filing, update, press-release
TL;DR
iHuman Inc. dropped a June 6-K with a press release. Check it out.
AI Summary
iHuman Inc. filed a Form 6-K on June 28, 2024, reporting information for the month of June 2024. The filing includes a press release as Exhibit 99.1. Vivien Weiwei Wang, Director and Chief Financial Officer, signed the report on behalf of the company.
Why It Matters
This filing provides an update on iHuman Inc.'s activities and disclosures for June 2024, which could contain material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains updates or press releases and does not inherently signal significant new risks.
Key Numbers
- 001-39591 — Commission File Number (Identifies the specific SEC filing for iHuman Inc.)
Key Players & Entities
- iHuman Inc. (company) — Registrant
- Vivien Weiwei Wang (person) — Director and Chief Financial Officer
- 001-39591 (dollar_amount) — Commission File Number
- June 2024 (date) — Reporting period
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information for the month of June 2024, including a press release as Exhibit 99.1.
Who signed the Form 6-K on behalf of iHuman Inc.?
Vivien Weiwei Wang, Director and Chief Financial Officer, signed the Form 6-K on behalf of iHuman Inc.
What is the Commission File Number for iHuman Inc.?
The Commission File Number for iHuman Inc. is 001-39591.
What is the principal executive office address for iHuman Inc.?
The principal executive office address for iHuman Inc. is Floor 8, Building B, No. 1 Wangjing East Road, Chaoyang District, Beijing 100102, People's Republic of China.
What exhibit is included with this Form 6-K filing?
Exhibit 99.1, a Press Release, is included with this Form 6-K filing.
Filing Stats: 153 words · 1 min read · ~1 pages · Grade level 9.9 · Accepted 2024-06-28 06:55:38
Filing Documents
- tm2418503d1_6k.htm (6-K) — 10KB
- tm2418503d1_ex99-1.htm (EX-99.1) — 146KB
- tm2418503d1_ex99-1img001.jpg (GRAPHIC) — 7KB
- 0001104659-24-075960.txt ( ) — 167KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. iHuman Inc. By : /s/ Vivien Weiwei Wang Name : Vivien Weiwei Wang Title : Director and Chief Financial Officer Date: June 28 , 2024